TCM
AMED

Teza Capital Management’s Amedisys AMED Stock Holding History

Teza Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,624
Closed -$975K – 587
2024
Q2 		$975K Buy
10,624
+5,700
+116% +$529K 0.12% 244
2024
Q1 		$454K Buy
+4,924
New +$461K 0.06% 354
2023
Q4 		– Sell
-7,517
Closed -$702K – 544
2023
Q3 		$702K Buy
+7,517
New +$695K 0.11% 254
2023
Q2 		– Sell
-5,045
Closed -$371K – 563
2023
Q1 		$371K Buy
+5,045
New +$436K 0.08% 331
2020
Q3 		– Sell
-1,523
Closed -$302K – 364
2020
Q2 		$302K Buy
+1,523
New +$284K 0.07% 392

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Teza Capital Management's AMED Position: Q3 2024 in Review

Teza Capital Management sold out of Amedisys (AMED) in Q3 2024, closing a stake of 10,624 shares — an estimated $975K sold.

Teza Capital Management first reported a position in AMED in Q2 2020 and held it in 5 quarters. The position peaked at $975K in Q2 2024. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • Teza Capital Management reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • Teza Capital Management sold 10,624 Amedisys shares in Q3 2024, an estimated $975K.
  • Teza Capital Management first reported a position in Amedisys in Q2 2020 and held it in 5 quarters.
  • Teza Capital Management's Amedisys position peaked at $975K in Q2 2024.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Teza Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.